Brokerages Set Rhoen Klinikum AG (ETR:RHK) Price Target at $22.17

Rhoen Klinikum AG (ETR:RHK) has earned a consensus recommendation of “Sell” from the seven ratings firms that are covering the firm, Marketbeat.com reports. Four analysts have rated the stock with a sell rating and three have given a hold rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is €22.17 ($25.78).

A number of equities analysts have weighed in on RHK shares. Credit Suisse Group set a €16.50 ($19.19) price objective on shares of Rhoen Klinikum and gave the stock a “sell” rating in a research report on Friday, May 10th. Independent Research set a €27.00 ($31.40) price objective on shares of Rhoen Klinikum and gave the stock a “neutral” rating in a research report on Friday, May 10th. Warburg Research set a €25.50 ($29.65) price objective on shares of Rhoen Klinikum and gave the stock a “neutral” rating in a research report on Thursday, April 11th. Berenberg Bank set a €26.20 ($30.47) price objective on shares of Rhoen Klinikum and gave the stock a “neutral” rating in a research report on Friday, May 3rd. Finally, Kepler Capital Markets set a €19.00 ($22.09) price objective on shares of Rhoen Klinikum and gave the stock a “sell” rating in a research report on Monday, April 1st.

ETR:RHK opened at €26.55 ($30.87) on Thursday. The company has a debt-to-equity ratio of 9.74, a current ratio of 1.76 and a quick ratio of 1.61. The business’s fifty day moving average is €25.93. The firm has a market capitalization of $1.78 billion and a PE ratio of 37.93. Rhoen Klinikum has a fifty-two week low of €21.06 ($24.49) and a fifty-two week high of €27.35 ($31.80).

Rhoen Klinikum Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

Featured Article: What is a Leveraged Buyout (LBO)?

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.